Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17978230rdf:typepubmed:Citationlld:pubmed
pubmed-article:17978230lifeskim:mentionsumls-concept:C1900409lld:lifeskim
pubmed-article:17978230lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:17978230lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:17978230lifeskim:mentionsumls-concept:C2348205lld:lifeskim
pubmed-article:17978230pubmed:issuePt 11lld:pubmed
pubmed-article:17978230pubmed:dateCreated2007-11-5lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:abstractTextA collection of eight clinical strains from Belgian hospitals and three clinical strains of the CCUG collection were characterized biochemically as being similar to CDC groups II-h and II-c; the latter differs from group II-h only by positivity for sucrose acidification. These 11 strains were found to cluster according to 16S rRNA gene sequence similarity at a level of >or=99.5%, and on the basis of their tDNA-PCR profile. Based on 16S rRNA gene sequence analysis, this collection of strains was related most closely to Chryseobacterium hispanicum (97.2%), but they differed from the type strain of this species by the following phenotypic characteristics: growth at 37 degrees C, negativity for xylose acidification, positivity for acetate assimilation-alkalinization on Simmons' agar base and absence of flexirubin pigments, and by their tDNA-PCR profile. Strain NF802T showed only 57.8% DNA-DNA relatedness to the type strain of C. hispanicum. Fatty acid composition did not enable differentiation from C. hispanicum. The DNA G+C content of strain NF802T is 36.5 mol%. The name Chryseobacterium hominis sp. nov. is proposed for this taxon, with type strain NF802T (=CCUG 52711T=CIP 109415T).lld:pubmed
pubmed-article:17978230pubmed:languageenglld:pubmed
pubmed-article:17978230pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:citationSubsetIMlld:pubmed
pubmed-article:17978230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17978230pubmed:statusMEDLINElld:pubmed
pubmed-article:17978230pubmed:monthNovlld:pubmed
pubmed-article:17978230pubmed:issn1466-5026lld:pubmed
pubmed-article:17978230pubmed:authorpubmed-author:VaneechoutteM...lld:pubmed
pubmed-article:17978230pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:17978230pubmed:authorpubmed-author:JanssensMichè...lld:pubmed
pubmed-article:17978230pubmed:authorpubmed-author:AvesaniVéroni...lld:pubmed
pubmed-article:17978230pubmed:authorpubmed-author:WautersGeorge...lld:pubmed
pubmed-article:17978230pubmed:authorpubmed-author:KämpferPeterPlld:pubmed
pubmed-article:17978230pubmed:issnTypePrintlld:pubmed
pubmed-article:17978230pubmed:volume57lld:pubmed
pubmed-article:17978230pubmed:ownerNLMlld:pubmed
pubmed-article:17978230pubmed:authorsCompleteYlld:pubmed
pubmed-article:17978230pubmed:pagination2623-8lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:meshHeadingpubmed-meshheading:17978230...lld:pubmed
pubmed-article:17978230pubmed:year2007lld:pubmed
pubmed-article:17978230pubmed:articleTitleChryseobacterium hominis sp. nov., to accommodate clinical isolates biochemically similar to CDC groups II-h and II-c.lld:pubmed
pubmed-article:17978230pubmed:affiliationDepartment of Clinical Chemistry, Microbiology and Immunology, University of Ghent, Ghent, Belgium. Mario.Vaneechoutte@UGent.belld:pubmed
pubmed-article:17978230pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17978230pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed